HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Makoto Emoto Selected Research

Vomiting

7/2008[The efficacy and safety of indisetron hydrochloride for the management of nausea/vomiting caused by chemotherapy for gynecologic cancer].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Makoto Emoto Research Topics

Disease

16Neoplasms (Cancer)
09/2015 - 04/2003
8Carcinosarcoma
09/2015 - 04/2003
5Sarcoma (Soft Tissue Sarcoma)
04/2014 - 12/2004
3Endometrial Neoplasms (Endometrial Cancer)
12/2010 - 04/2003
3Breast Neoplasms (Breast Cancer)
08/2009 - 11/2003
2Body Weight (Weight, Body)
09/2015 - 04/2010
2Carcinoma (Carcinomatosis)
12/2004 - 04/2003
2Endometrial Hyperplasia
11/2003 - 04/2003
1Hemorrhage
08/2011
1Neoplasm Metastasis (Metastasis)
04/2010
1Leiomyosarcoma
04/2010
1Cysts
08/2009
1Endometriosis
08/2009
1Fibrosis (Cirrhosis)
08/2009
1Nausea
07/2008
1Vomiting
07/2008
1Ovarian Cysts (Ovarian Cyst)
03/2006
1Polyps
11/2003
1Ovarian Neoplasms (Ovarian Cancer)
10/2003
1Weight Loss (Weight Reduction)
04/2003
1Lymphatic Metastasis
04/2003
1Ataxia (Dyssynergia)
04/2003

Drug/Important Bio-Agent (IBA)

6O-(Chloroacetylcarbamoyl)fumagillol (TNP 470)IBA
08/2011 - 04/2003
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2014 - 04/2003
3Angiogenesis InhibitorsIBA
04/2014 - 04/2003
3TamoxifenFDA LinkGeneric
08/2009 - 11/2003
2calcium phosphateIBA
09/2015 - 04/2010
2DNA (Deoxyribonucleic Acid)IBA
08/2009 - 11/2003
2Contrast MediaIBA
06/2007 - 10/2003
14-chlorophenyl methyl sulfide (CPMS)IBA
09/2015
1azaspireneIBA
05/2015
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
04/2014
1Thrombospondin 1IBA
04/2014
1Liposomes (Liposome)IBA
01/2013
1Progesterone Receptors (Progesterone Receptor)IBA
10/2011
1Estrogens (Estrogen)FDA Link
10/2011
1Membrane Glycoproteins (Membrane Glycoprotein)IBA
10/2011
1VimentinIBA
10/2011
1Epithelial Cell Adhesion MoleculeIBA
10/2011
1doxifluridineIBA
08/2011
1Biomarkers (Surrogate Marker)IBA
02/2011
1Irinotecan (Camptosar)FDA LinkGeneric
02/2011
1Danazol (Azol)FDA LinkGeneric
08/2009
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
08/2009
1Paclitaxel (Taxol)FDA LinkGeneric
07/2008
15-HT3 Serotonin Receptors (5 HT3 Receptor)IBA
07/2008
1Docetaxel (Taxotere)FDA Link
07/2008
1Carboplatin (JM8)FDA LinkGeneric
07/2008
1indisetron hydrochlorideIBA
07/2008
1Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric
03/2006
1JNK Mitogen-Activated Protein KinasesIBA
03/2005
1Messenger RNA (mRNA)IBA
12/2004
1AngiopoietinsIBA
12/2004
1Vascular Endothelial Growth FactorsIBA
12/2004
1Codon (Codons)IBA
11/2003
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
04/2003
1Vascular Endothelial Growth Factor DIBA
04/2003
1Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
04/2003
1fumagillinIBA
04/2003

Therapy/Procedure

8Therapeutics
04/2014 - 04/2003
6Radiotherapy
09/2015 - 04/2003
5Drug Therapy (Chemotherapy)
05/2015 - 07/2008
2Microspheres (Microsphere)
09/2015 - 04/2010
2Microbubbles
06/2007 - 10/2003
1Lasers (Laser)
08/2011
1Hysterectomy
12/2010
1Aftercare (After-Treatment)
04/2010
1Laparotomy
04/2010
1Cystectomy
08/2009